Evidence map›Paper›PMID 32848178›Full record

ArticleScientific reports2020

Post-translational modification as a response to cellular stress induced by hemoglobin oxidation in sickle cell disease.

Michael Brad Strader, Sirsendu Jana, Fantao Meng, Michael R Heaven, Arun S Shet, Swee Lay Thein, Abdu I Alayash

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Redox stress in COVID-19: Implications for hematologic disorders.Best practice & research. Clinical haematology · 2022
    Review
  14. Article
  15. Article
  16. Review
  17. Hemoglobin Oxidation Reactions in Stored Blood.Antioxidants (Basel, Switzerland) · 2022
    Article
  18. Article
  19. Hemoglobin can Act as a (Pseudo)-PeroxidaseFrontiers in molecular biosciences · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Michael Brad Strader *Laboratory of Biochemistry and Vascular Biology, Center for Biologics Evaluation and Research, Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Building 52/72, Room 4106, Silver Spring, MD, 20993, USA.
Sirsendu Jana *Laboratory of Biochemistry and Vascular Biology, Center for Biologics Evaluation and Research, Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Building 52/72, Room 4106, Silver Spring, MD, 20993, USA.
Fantao MengHemoglobin Oxygen Therapeutics, Souderton, PA, USA.
Michael R HeavenVulcan Biosciences, Birmingham, AL, 35203, USA.
Arun S ShetSickle Cell Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, 20892-0520, USA.
Swee Lay TheinSickle Cell Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, 20892-0520, USA.
Abdu I AlayashLaboratory of Biochemistry and Vascular Biology, Center for Biologics Evaluation and Research, Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Building 52/72, Room 4106, Silver Spring, MD, 20993, USA. abdu.alayash@fda.hhs.gov.
Center for Biologics Evaluation and Research · USNational Institutes of Health · USVulcan (United States) · US

Funding

Recombinant HbAp Production for In Vivo Toxicity StudiesP01HL110900 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI FRIEDMAN, JOEL M · 2012 to 2016
$10.6M
NHLBI NIH HHS P01 HL110900
6 · The paper itself

Abstract

Intracellular oxidative stress and oxidative modification of sickle hemoglobin (HbS) play a role in sickle cell disease (SCD) pathogenesis. Recently, we reported that Hb-dependent oxidative stress induced post-translational modifications (PTMs) of Hb and red blood cell (RBC) membrane proteins of transgenic SCD mice. To identify the mechanistic basis of these protein modifications, we followed in vitro oxidative changes occurring in intracellular Hb obtained from RBCs and RBC-derived microparticles (MPs) from the blood of 23 SCD patients (HbSS) of which 11 were on, and 12, off hydroxyurea (HU) treatment, and 5 ethnic matched controls. We used mass spectrometry-based proteomics to characterize these oxidative PTMs on a cross-sectional group of these patients (n = 4) and a separate subgroup of patients (n = 2) studied prior to initiation and during HU treatment. Collectively, these data indicated that band-3 and its interaction network involved in MPs formation exhibited more protein phosphorylation and ubiquitination in SCD patients than in controls. HU treatment reversed these oxidative PTMs back to level observed in controls. These PTMs were also confirmed using orthogonal immunoprecipitation experiments. Moreover, we observed specific markers reflective of oxidative stress, including irreversible oxidation of βCys93 and ubiquitination of Hb βLys145 (and βLys96). Overall, these studies strongly suggest that extensive erythrocyte membrane protein phosphorylation and ubiquitination are involved in SCD pathogenesis and provide further insight into the multifaceted effects of HU treatment.

Indexed as

Protein Processing, Post-TranslationalAdultAnemia, Sickle CellCase-Control StudiesChildErythrocytesFemaleHemoglobinsHumansHydroxyureaMaleMiddle AgedOxidation-ReductionOxidative StressProteasome Endopeptidase ComplexYoung AdultHemoglobinsHydroxyureaProteasome Endopeptidase Complex

Identifiers

PMID32848178
PMCPMC7450072
OpenAlexW3081481522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.